Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,772 | 200,481 | 237,170 | 67,019 | 62,436 |
| Marketable Securities | 276,817 | 255,786 | 220,206 | 289,441 | 336,088 |
| Receivables | 33,067 | 28,640 | 34,186 | 18,085 | 19,443 |
| Inventories | 7,608 | 7,259 | 6,286 | 6,593 | 6,082 |
| TOTAL | $410,407 | $497,682 | $505,562 | $406,630 | $429,064 |
| Non-Current Assets | |||||
| PPE Net | 9,418 | 5,696 | 2,930 | 2,617 | 2,891 |
| Intangibles | 154,125 | 155,153 | 156,307 | 157,013 | 158,136 |
| Other Non-Current Assets | 33,489 | 33,689 | 13,895 | 6,803 | 14,709 |
| TOTAL | $197,032 | $194,538 | $173,132 | $166,433 | $175,736 |
| Total Assets | $607,439 | $692,220 | $678,694 | $573,063 | $604,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,133 | 9,431 | 10,198 | 9,966 | 26,614 |
| Accrued Expenses | 56,793 | 50,320 | 44,379 | 41,590 | 51,745 |
| Other current liabilities | 23,377 | 15,675 | 15,356 | 16,535 | 17,090 |
| TOTAL | $92,660 | $75,426 | $69,933 | $68,091 | $95,449 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 303,566 | 315,381 | 290,116 | 279,224 | 288,155 |
| TOTAL | $303,566 | $315,381 | $290,116 | $279,224 | $288,155 |
| Total Liabilities | $396,226 | $390,807 | $360,049 | $347,315 | $383,604 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,236 | 51,052 | 50,906 | 43,156 | 43,116 |
| Common Shares | 5 | 5 | 5 | 4 | 4 |
| Retained earnings | -585,875 | -464,253 | -441,704 | -415,636 | -416,444 |
| Other shareholders' equity | -902 | 354 | 1,399 | -1,500 | 726 |
| TOTAL | $211,213 | $301,413 | $318,645 | $225,748 | $221,196 |
| Total Liabilities And Equity | $607,439 | $692,220 | $678,694 | $573,063 | $604,800 |